P021 is a small neurotrophic and neurogenic peptide mimetic compound, developed to avoid the blood-brain barrier impermeability, short half-life and side effects that halted trials of whole neurotrophic factor proteins in Alzheimer's disease.
preclinical — animal, cell or mechanistic work — not yet about people
every claim resolves to its source
All 1 citation resolves to their original source. · 0 posts naming it, 0 members counted once each.
created page created as 'P21' · 2026-09-27 04:00 · somebody
kind set kind set to peptide: palette r1 · 2026-09-27 04:00 · somebody
identity withheld identity not published: PubChem gave no record that proves it is this substance · 2026-09-27 04:00 · somebody
fact added summary: P021 is a small neurotrophic and neurogenic peptide mimetic compound, developed to avoid the blood-brain barrier imperme · 2026-09-27 04:00 · somebody
citation added pmid 36291618 cited as preclinical: Review of pre-clinical studies of the neurotrophic peptide mimetic P021 · 2026-09-27 04:00 · somebody
question added Is the compound sold as P21 the same as the published neurotrophic peptide mimetic P021? · 2026-09-27 04:00 · somebody
Negative findings
failure is information
Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.